Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic δ-opioid agonist treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 1, 2003, Pages 109-115

  Varga, Eva V ^a,b   Rubenzik, Marc K ^a   Stropova, Dagmar ^a   Sugiyama, Masano ^a   Grife, Vanessa ^a   Hruby, Victor J ^a   Rice, Kenner C ^c   Roeske, William R ^a,b   Yamamura, Henry I ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDINE 5 IODO 1,3 DIHYDROINDOL 2 ONE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ADENYLATE CYCLASE; CALMIDAZOLIUM; CALMODULIN INHIBITOR; CHELERYTHRINE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN [2,5 DEXTRO PENICILLAMINE]; ENZYME ANTIBODY; FORSKOLIN; GENISTEIN; GW 5074; PHOSPHORUS 32; PROTEIN INHIBITOR; PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CHINESE HAMSTER; CHO CELL; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME METABOLISM; GENETIC TRANSFECTION; IMMUNOREACTIVITY; LONG TERM CARE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENYLATE CYCLASE; ANIMALS; BENZAMIDES; CHO CELLS; CRICETINAE; CYCLIC AMP; ENZYME ACTIVATION; FEMALE; FORSKOLIN; HUMANS; PHOSPHORYLATION; PIPERAZINES; PROTEIN KINASES; RECEPTORS, OPIOID, DELTA; TRANSFECTION;

EID: 0038340971     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.049643     Document Type: Article

References (30)

1. Sα. Mol Pharmacol 52:993-999.
2. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Lebovitz N, Nevo I, and Vogel Z (1995) Adenylyl cyclase supersensitization in μ-opioid receptor transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270:29732-29738.
3. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. J Biol Chem 271:21309-21315.
4. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isoenzyme-specific. J Biol Chem 272:5040-5047.
5. Bayewitch M, Nevo I, Avidor-Reiss T, Levy R, Simmonds WF, and Vogel Z (2000) Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of Gi/o-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol Pharmacol 57:820-825.
6. Belcheva MM and Coscia CJ (2002) Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11:34-44.
7. Belcheva MM, Szucs M, Wang D, Sadee W, and Coscia CJ (2001) Mu opioid receptor-mediated ERK activation involves calmodulin dependent EGF receptor transactivation. J Biol Chem 276:33847-33853.
8. Chakrabarti S, Wang L, Tang W-J, and Gintzler AR (1998) Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol Pharmacol 54:949-953.
9. Crain SM and Shen KF (1998) Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated, opioid receptor functions. Trends Pharmacol Sci 19:358-365.
10. Cumbay MG and Watts VJ (2001) Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors. J Pharmacol Exp Ther 297:1201-1209.
11. 2+ and calmodulin. Mol Cell Biol 20:1931-1946.
12. Fukuda K, Kato S, Morikawa H, Shoda T, and Mori K (1996) Functional coupling of δ, μ and κ-opioid receptors to MAP kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67:1309-1316.
13. 2+-transport and of calmodulin-regulated functions. Biochem Biophys Res Commun 101:418-428.
14. Ishikawa Y (1998) Regulation of cAMP signaling by phosphorylation. Adv Second Messenger Phosphoprotein Res 32:99-120.
15. Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, et al. (1994) Identification of a human δ opioid receptor: cloning and expression. Life Sci 54:PL463-PL469.
16. Law P-Y and Loh HH (1993) Delta opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma × glioma NG108-15 hybrid cells. Mol Pharmacol 43:684-693.
17. Malatynska E, Wang Y, Knapp RJ, Santoro G, Waite S, Roeske WR, and Yamamura HI (1995) Human δ opioid receptor: a stable cell line for functional studies of opioids. Neuroreport 6:613-616.
18. Malatynska E, Wang Y, Knapp RJ, Waite S, Calderon S, Rice KC, Hruby VJ, Yamamura HI, and Roeske WR (1996) Human δ-opioid receptor: functional studies on stably transfected CHO cells following acute and chronic treatment with the selective non-peptidic agonist SNC-80. J Pharmacol Exp Ther 278:1083-1089.
19. Nestler E and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science (Wash DC) 278:58-63.
20. Rivera M and Gintzler AR (1998) Differential effect of chronic morphine on mRNA encoding adenylyl cyclase isoforms: relevance to physiological sequela of tolerance/dependence. Mol Brain Res 54:165-169.
21. Rubenzik M (2002) The Molecular Mechanism of Chronic δ-Opioid-Mediated Adenylyl Cyclase Superactivation in Chinese Hamster Ovary Cells Stably Suppressing the δ-Opioid Receptor: A Cellular Model for Tolerance and Withdrawal. Ph.D. thesis, The University of Arizona, Tucson.
22. Rubenzik M, Varga EV, Stropova D, Roeske WR, and Yamamura HI (2001) Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates agonist-induced adenylyl cyclase superactivation. Mol Pharmacol 60:1076-1082.
23. Sharma SK, Klee WA, and Nirenberg M (1975) Dual regulation of adenylyl cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
24. Tan CM, Kelvin DJ, Litchfield DW, Ferguson SSG, and Feldman RD (2001) Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40:1702-1709.
25. Thomas JM and Hoffman BB (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-914.
26. vanVliet BJ, DeVries TJ, Wardeh G, Mulder AH, and Schoffelmeer ANM (1991) μ-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur J Pharmacol 208:105-111.
27. Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, and Yamamura HI (2002) Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur J Pharmacol 451:101-103.
28. Varga EV, Stropova D, Rubenzik M, Waite S, Roeske WR, and Yamamura HI (1999) Phosphorylation of adenylyl cyclase VI upon chronic δ-opioid receptor stimulation. Eur J Pharmacol 364:R1-R2.
29. Varga EV, Stropova D, Rubenzik M, Wang M, Landsman RS, Roeske WR, and Yamamura HI (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur J Pharmacol 348:R1-R2.
30. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.